← back to search

Wei Yu

Harbin Medical University · CN
Area of research
Molecular Biology · Mechanical Engineering
Research interest
Research interests include Medicine, Ischemia, Reperfusion injury, Propofol, Neuroinflammation, and Dysbiosis.
h-index
citations
190
works
9
NIH funding
primary concept
email

Recent publications

Lithium attenuates ketamine-induced long-term neurotoxicity through DISC1-mediated GSK-3β/β-catenin and ERK/CREB pathways
Toxicology Letters 2025cited by 2position: middledoi
47P First-line pembrolizumab (pembro) + gemcitabine and cisplatin (gem/cis) for advanced biliary tract cancer (BTC) in the China subpopulation from the phase III KEYNOTE-966 study
Annals of Oncology 2024cited by 3position: middledoi
799MO The primary results from a randomized double-blind phase II study of rovadicitinib versus hydroxyurea in patients with myelofibrosis
Annals of Oncology 2024cited by 2position: middledoi
Dexmedetomidine Alleviates the Long-Term Neurodevelopmental Toxicity Induced by Sevoflurane in the Developing Brain
Developmental Neuroscience 2024cited by 2position: middledoi
Propofol Ameliorates Microglia Activation by Targeting MicroRNA-221/222-IRF2 Axis
Journal of Immunology Research 2021cited by 11position: middledoi
Intestinal Flora Dysbiosis Aggravates Cognitive Dysfunction Associated With Neuroinflammation in Heart Failure
Journal of Cardiac Failure 2020cited by 24position: firstdoi
Probiotics alleviate cognitive dysfunction associated with neuroinflammation in cardiac surgery.
PubMed 2019cited by 11position: first
Propofol Prevents Oxidative Stress by Decreasing the Ischemic Accumulation of Succinate in Focal Cerebral Ischemia–Reperfusion Injury
Neurochemical Research 2017cited by 46position: firstdoi
Reperfusion Promotes Mitochondrial Dysfunction following Focal Cerebral Ischemia in Rats
PLoS ONE 2012cited by 89position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Jin Wen · Mayo Clinic3 papers (2017–2020)Sihua Qi · Harbin Medical University3 papers (2012–2021)Dapeng Gao · Ningbo University3 papers (2017–2020)Sihua Qi · Harbin Medical University2 papers (2017–2019)Xiaowei Peng · Harbin Medical University2 papers (2019–2020)Ayang Zhao · Harbin Medical University2 papers (2019–2020)Zhang Shu-jun · Harbin Medical University2 papers (2024–2025)Jia Liu · Harbin Medical University2 papers (2024–2025)Peng Yu · Harbin Medical University2 papers (2024–2025)Tingting Yang · National University of Singapore2 papers (2024–2025)Fang Zhang · Shandong University2 papers (2024–2025)Chenghong Peng · Union Hospital1 papers (2024–2024) · 1 papers (2024–2024)Tao Gong · Shanxi Medical University1 papers (2024–2024)Hongfeng Gou · National Cancer Center1 papers (2024–2024)Hao Su · Hebei Agricultural University1 papers (2024–2024)Usha Malhotra · Merck & Co., Inc., Rahway, NJ, USA (United States)1 papers (2024–2024)Yongrui Bai · Jiangmen Central Hospital1 papers (2024–2024)Sophie Z. Gu · Johns Hopkins Medicine1 papers (2024–2024)Baozhong Shen · Harbin Medical University1 papers (2012–2012)